NPR News Now
NPR News Now

NPR News: 04-01-2026 2PM EDT

April 1, 2026

AI Summary

5 min read

NPR's news roundup covers Supreme Court arguments on birthright citizenship, President Trump's planned address on the ongoing Iran war, a new FDA-approved obesity drug, NASA's Artemis II preparations amid shifting diversity messaging, and business updates including Hershey's recipe reversal and a rising Dow.

Supreme Court Skeptical of Ending Birthright Citizenship

The U.S. Supreme Court heard arguments challenging President Trump's executive order, issued on his first day back in office, to end birthright citizenship for babies born to undocumented immigrants or those on temporary visas or work permits. A majority of justices, including some Trump appointees, appeared skeptical of the administration's position. Challengers' attorney Cecilia Wong argued that upholding the order would rewrite the Constitution and disrupt over 150 years of precedent. Trump attended the solicitor general's presentation but left before Wong spoke. If upheld, the order could impact 250,000 U.S.-born babies annually and potentially allow revocation of citizenship for others born earlier. A decision is due by summer's end.

Continue reading the full summary in the app — free to try.

Read Full Summary →

Free • No credit card required

What you'll learn

  • 1 (00:01) **Supreme Court Skeptical on Birthright Citizenship** - Majority of justices question Trump's executive order limiting constitutional provision
  • 2 (00:26) **Potential Impact of Ending Birthright Citizenship** - Could affect 250K babies yearly and revoke prior citizenships
  • 3 (00:46) **Challengers Argue Against Trump's Order** - Attorney warns it would rewrite Constitution and upend 150+ years of law
  • 4 (01:09) **Trump to Address Iran War Tonight** - War in fifth week with thousands of US troops in region
  • 5 (01:31) **Disputed Ceasefire Claims on Social Media** - Trump says Iran's new leader requested ceasefire if Strait of Hormuz opens
  • 6 (01:59) **FDA Approves Eli Lilly Obesity Pill** - New oral drug Fundeo from makers of Zepbound injectable
  • 7 (02:44) **Pricing for New Obesity Pill** - Commercial insurance as low as $25/month; cash $149 for lowest dose

+ Full timestamped outline available in the app

Show Notes

NPR News: 04-01-2026 2PM EDT

To manage podcast ad preferences, review the links below:

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy
NPR News Now

More from this podcast

NPR News Now →